Statistical Issues

The two major statistical issues in asthma pharmacogenomics relate to population stratification and statistical power. 

---

Examples ofTypical QRA Objectives Types of Eacility Resotirces/Personnel Classical Limitations of QRA Example of Mortality Statistics Issues Affecting Perception of Risk Typical Pitfalls in Using QRA... 

EDWARDS s, KOCH G G, SOLLECITO w A, PEACE K E (1990) Siunmarizatiou, analysis, and monitoring of adverse experiences, in Statistical Issues in Drug Research and Development, New York, Marcel Dekker, Inc, 19-170. 

Olsen AR, Sedransk J, Edwards D, Gotway CA, Liggett Rathbun S, Reckhow KH, Young LJ. 1999. Statistical issues for monitoring ecological and natural resources in the United States. Environ Monit Assess 54 1 5. 

The E9 discusses the statistical issues in the design and conduct of a clinical trial. It details trial design, trial conduct, and data analysis and reporting. Although most useful... 

Multiple linear regression (MLR) is a classic mathematical multivariate regression analysis technique [39] that has been applied to quantitative structure-property relationship (QSPR) modeling. However, when using MLR there are some aspects, with respect to statistical issues, that the researcher must be aware of ... 

Hajian, G. (1983). Statistical issues in the design and analysis of carcinogenicity bioassays. Toxicol. Pathol. 11 83-89. 

Thakur, A.K. (2000). Statistical issues in large animal toxicology. Ini. J. Toxicol. 19 133-140. 

Nadon, R. and Shoemaker, J., Statistical issues with microarrays processing and analysis, Trends Genet., 18, 265, 2002. 

Smyth GK, Yang YH, Speed T. 2003. Statistical issues in cDNA microarray data analysis. Methods Mol Biol 224 111. 

Statistical Issues in Measuring Airborne Asbestos Levels Following an Abatement Program... 

Senn SJ. Cross-over, Sequential and Dose Finding Studies. Statistical Issues in Drug Development. Chichester John Wiley, 1997 237-9 257-64 275-7. 

Albert JM, loannidis JPA, Reichelderfer P, et al. Statistical issues for HIV surrogate endpoints point/counterpoint. Stat Med 1998 17 2435-62. 

For example, the distribution from which the samples are drawn is assumed to be the true distribution of the parameter of interest. To the degree that the sample distribution differs from the actual distribution (which is generally assumed unknown by the classical statistician), the confidence in the Monte Carlo results is decreased. Just how close these distributions must be is a complicated statistical issue that is frequently unclear. In a practical sense, if misspecification of a sampling distribution occurs for a very sensitive parameter in a multiparameter model, then the confidence in the Monte Carlo results is greatly diminished because the model prediction is greatly influenced by that parameter. 

Since that time we have seen numerous additional guidelines on specific statistical issues, for example the European (CPMP/CHMP) Points to Consider Papers ... 

Both the EMEA and the EDA have recognised the need to streamline the drug development process in order to bring new medicines to patients more rapidly see for example FDA (2004) Critical Path Initiative . The FDA raise (FDA (2006) Critical Path Opportunities List ) a number of statistical issues that need to be resolved in order to help make the clinical trials process more efficient ... 

Senn S (1997) Statistical Issues in Drug Development Chichester. John WUey Sons, Ltd Senn S (2002) Cross-Over Trials in Clinical Research (2nd edn) Chichester John WUey Sons Senn S (2003) Disappointing dichotomies. Pharmaceutical Statistics, 2, 239-240 Sherman DG, Atkinson RP, Chippendale T et al (2000) Intravenous ancrod for treatment of acute ischemic stroke the STAT study a randomised controUed trial. Journal of the American Medical Association, 283, 2395-2403... 

The aim of the book is not to turn non-statisticians into statisticians. I do not want you to go away from this book and do statistics. It is the job of the statistician to provide statistical input to the development plan, to individual protocols, to write the statistical analysis plan, to analyse the data and to work with medical writing in producing the clinical report also to support the company in its interactions with regulators on statistical issues. 

The process is more involved than this in practice, and steps are required to deal with statistical issues. For example, rogue or outlier lakes should be identified to avoid unrealistic estimates of taxa optima (see ref. 17 for objective procedures to identify rogues). Also, steps must be taken to account... 

Another statistical issue is the relationship between the composition in the calibration set used to derive the transfer functions and the lakes for which the transfer functions will be applied. Calibration data sets should be modified if used to reconstruct chemistry of different types of lakes. A subset of calibration lakes can be selected that does not contain lakes so different that they might unduly influence optimum environmental values for a taxon (for example, saline lakes can be removed from a calibration data set to be used for generating data to infer trophic-state change in low-conductivity lakes). 

Smith WC, Sittampalam GS Conceptual and statistical issues in the validation of analytic dilution assays for pharmaceutical applications./. Biopharm. Statistics (1998) 8 509-532. 

The chapters in this part of the book discuss both clinical and statistical issues and illustrate how they are combined together for the ultimate benefit of patients. 

Senn, S., 1997, Statistical issues in drug development, John Wiley Sons. 

Parmigiani Modeling in Medical Decision Making A Bayesian Approach Senn Cross-over Trials in Clinical Research, Second Edition Senn Statistical Issues in Drug Development... 

---